Chronic myeloid leukemia (CML) is a type of hematological malignancy that is often caused by the BCR (breakpoint cluster region)–ABL (Abelson proto-oncogene), a fusion product of BCR and ABL kinase triggered by chromosome translocation (1, 2). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.